Questions or feedback? Write to contact@adhdw.com

A clear, well-sourced guide

Understanding attention — the ADHD way & world.

ADHD is one of the most common neurodevelopmental conditions in the world. This site gathers what major health agencies and peer-reviewed research actually say — in plain language.

Scroll to explore
11.7%
of U.S. children aged 3–17 had a current ADHD diagnosis
NSCH 2024
7.1M
U.S. children with current ADHD — about one in nine (2024)
NSCH 2024
366M
adults worldwide with symptomatic adult ADHD — a 2020-era estimate, not a current headcount
Song et al., 2021
77.9%
of U.S. children with current ADHD had a co-occurring condition (2022 data)
Danielson et al., 2024

Please read first. The author of adhdw.com is not a doctor, psychologist or medical professional. This site is for general education only and is not a substitute for professional medical advice, diagnosis or treatment. Parts of it were researched and drafted with the help of AI tools, which can make mistakes — always verify important information with primary sources and a qualified healthcare provider.

The ADHD Report — Part I

About ADHD

A detailed, plainly written overview of attention-deficit/hyperactivity disorder, with inline citations to government health agencies and peer-reviewed research. Full reference list at the end.

Attention-deficit/hyperactivity disorder — ADHD — is one of the most common neurodevelopmental disorders. It is typically first identified in childhood and often continues into adolescence and adulthood.[3][1]

It is defined by an ongoing pattern of inattention, hyperactivity and/or impulsivity that interferes with everyday functioning or development.[4][10] Almost everyone is occasionally distracted or restless — but in ADHD these traits are more frequent and intense, appear in more than one setting, and create genuine difficulty in daily life.[4]

1 What ADHD is

A difference in how the brain develops and works

ADHD is classified as a neurodevelopmental disorder, meaning it is rooted in differences in how the brain develops and functions.[3][10] Both the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) and the World Health Organization's International Classification of Diseases (ICD-11) recognise ADHD within this category.[10][14]

Research links ADHD to differences across distributed brain networks involved in attention, motivation, executive control and self-regulation, and the dopamine and noradrenaline systems are involved in these processes.[3][11] There is no single “ADHD brain,” however: ADHD is not adequately explained by one neurotransmitter or one brain region, and no brain scan can diagnose it.[3]

Key point

ADHD is a recognised medical condition. It is not caused by laziness, low intelligence or poor parenting, and a person with ADHD can be highly capable.[4]

2 A brief history

More than a century of observation

Descriptions of ADHD-like behaviour appear in the medical literature well over a hundred years ago. In 1902, the British paediatrician Sir George Frederic Still delivered lectures describing children of normal intelligence who struggled to sustain attention and regulate their behaviour — what he then called a "defect of moral control."[13]

In 1937, Charles Bradley observed that stimulant medication improved behaviour and schoolwork in some children — a finding that shaped treatment for decades.[13] Through the mid-20th century the condition was studied under labels such as "minimal brain dysfunction."[13]

The American Psychiatric Association recognised it as "hyperkinetic reaction of childhood" in the DSM-II (1968) and reframed it as "attention deficit disorder" in the DSM-III (1980). Later editions adopted the modern name and the current understanding — including the recognition that ADHD can persist into adulthood — with the DSM-5 (2013) placing it firmly among the neurodevelopmental disorders.[13][10]

3 How common it is

A condition found across childhood and adulthood

ADHD is common worldwide. In the United States, the 2024 National Survey of Children's Health found that an estimated 11.7% of children aged 3–17 — about 7.1 million, or roughly 1 in 9 — had a current ADHD diagnosis (95% confidence interval 11.1–12.2%).[20] These are parent- or caregiver-reported survey estimates, not diagnoses independently confirmed from medical records.[20]

A current diagnosis was reported for about 14.5% of boys and 8.8% of girls, and prevalence rose with age — from 3.7% of boys and 1.6% of girls aged 3–5, to 16.2% and 8.7% at ages 6–11, to 17.5% and 12.0% at ages 12–17.[20] The earlier 2022 survey had found 11.4% of children ever diagnosed and 10.5% with a current diagnosis; the estimates are close, so the difference should not be read as a confirmed rise without a formal trend analysis.[1][2]

U.S. children with a current ADHD diagnosis, by age & sex (2024)
Share of children in each group, percent · coral = boys, teal = girls
3.7%
Boys 3–5
1.6%
Girls 3–5
16.2%
Boys 6–11
8.7%
Girls 6–11
17.5%
Boys 12–17
12.0%
Girls 12–17

Source: 2024 National Survey of Children's Health (NSCH), HRSA/MCHB; parent/caregiver-reported.[20]

ADHD is not only a childhood condition. A 2021 global systematic review and meta-analysis estimated that, after adjusting for the world's population structure, about 2.6% of adults have persistent ADHD (childhood-onset ADHD continuing into adulthood) and about 6.8% have symptomatic adult ADHD (a broader estimate of adults meeting symptom-based criteria) — corresponding to roughly 140 million and 366 million adults worldwide, respectively.[9] These are historical epidemiological estimates based on evidence available up to about 2020, not a current headcount of adults living with ADHD today.

ADHD in girls and women is more likely to be missed or diagnosed late. This is not because it is rare in females but because it more often presents with inattentive or internalised difficulties rather than obvious hyperactivity; because girls and women may develop coping and masking strategies that hide their struggles; and because recognition and referral have historically been biased toward the more visible, stereotypically male presentation.[15] The gap between the sexes tends to narrow in adulthood, and lived-experience research reports that late recognition can carry a real cost — years of self-criticism, low self-esteem and missed support before diagnosis.[15][16]

The ADHD Report — Part II

Symptoms & diagnosis

ADHD is described through two groups of traits and three presentations. Diagnosis is made by a qualified professional using established clinical criteria.

4 Core symptoms

Two groups of traits

ADHD symptoms fall into two groups. Many people show some of these behaviours some of the time; in ADHD they are persistent and disruptive.[4]

Inattention

Difficulty sustaining focus, being easily distracted, careless mistakes, trouble following through on tasks and instructions, disorganisation, forgetfulness in daily activities, and frequently losing things.[4][3]

Hyperactivity & impulsivity

Fidgeting or squirming, restlessness, difficulty staying seated, excessive talking, interrupting others, and acting without thinking things through.[4][3]

5 The three presentations

How the DSM-5-TR describes ADHD

Under the DSM-5-TR, ADHD is described in three presentations, depending on which symptoms dominate: predominantly inattentive, predominantly hyperactive-impulsive, and combined.[10] Because predominant symptoms can change over time, a person's presentation may shift as they grow — which is why the DSM-5 uses the word "presentations" rather than fixed "subtypes."[11][10]

Predominantly inattentive

Mainly difficulties with attention, focus and organisation, with fewer hyperactive traits.[10]

Predominantly hyperactive-impulsive

Mainly restlessness, hyperactivity and impulsive actions, with fewer inattentive traits.[10]

Combined presentation

Meets the criteria for both inattention and hyperactivity-impulsivity together.[10]

6 Causes & risk factors

No single cause, but a strong genetic thread

There is no single cause of ADHD.[3] Genetics play a major role: ADHD runs in families, and twin studies point to a high degree of heritability.[11] Researchers continue to investigate genes, brain structure and activity, hormones and other molecules, and prenatal and early-life exposures.[3]

Risk factors that have been associated with ADHD include very low birth weight (under about 1,500 grams), prenatal exposure to alcohol or tobacco, exposure to environmental toxins such as lead, and head injury.[11] These are associations identified in research, not guaranteed causes; many children with these exposures never develop ADHD, and many children with ADHD have none of them.

7 How it is diagnosed

A careful clinical evaluation

There is no single test for ADHD.[11] A diagnosis is made by a qualified health professional using established clinical criteria, after gathering information from several sources — often parents, teachers and the individual — and after ruling out other explanations.[11]

Under the DSM-5-TR, several symptoms must have been present before age 12, must appear in two or more settings, must have lasted at least six months, and must clearly interfere with functioning.[10][11] Children generally need at least six symptoms from a symptom group, while older adolescents (17 and over) and adults need at least five.[10] The “before age 12” rule refers to when symptoms were present — it does not mean a person had to be diagnosed in childhood, or that their difficulties caused obvious problems at the time. Many people, especially those whose ADHD was overlooked, are first recognised as adults.[8]

Screening is not diagnosis

Rating scales, online quizzes and questionnaires can flag symptoms and help guide an assessment, but no single questionnaire, brain scan, blood test or cognitive test can establish an ADHD diagnosis on its own. A diagnosis comes from a qualified professional weighing the full picture.[11]

Why evaluation matters

Anxiety, depression, learning disorders, sleep problems and autism can look similar to ADHD or occur alongside it — so a thorough, professional evaluation is essential.[11][3]

8 Co-occurring conditions

ADHD rarely travels alone

ADHD frequently occurs together with other conditions. Among U.S. children with current ADHD in 2022, about 77.9% had at least one co-occurring disorder.[2] Common companions include behavioural or conduct problems, anxiety, depression, learning disorders, and autism spectrum disorder.[2][3] Co-occurring conditions can make ADHD harder to recognise and treat, which is another reason careful assessment matters.[3]

The ADHD Report — Part III

Treatment & living well

ADHD can usually be managed well with the right support. Recommended approaches vary by age and combine behavioural strategies, education and, where appropriate, medication.

9 Treatment & management

Support tailored to age

Treatment recommendations vary by age group.[5] For children under 6, the American Academy of Pediatrics recommends parent training in behaviour management as the first-line treatment, before medication, because young children are more likely to experience medication side effects.[5][6]

For children aged 6 and older, the recommendation is a combination of behaviour therapy and medication, ideally together, along with school supports.[5][6] Medications include stimulants — such as methylphenidate and amphetamine-based medicines, which are long-established and effective for many people — and non-stimulant options, first approved for ADHD in the early 2000s, which can help when stimulants are unsuitable.[5][6]

In adults, treatment commonly combines medication with psychotherapy or cognitive-behavioural strategies such as time-management and organisation skills.[7][8] Finding the right treatment can take time, and plans often need adjustment along the way.[5]

What newer evidence says

A 2025 umbrella review that re-analysed 221 meta-analyses found substantial short-term evidence for several ADHD medications — including methylphenidate, amphetamines, atomoxetine, alpha-2 agonists and viloxazine — while highlighting that high-certainty evidence for long-term outcomes remains limited.[17] A useful principle is to treat the person, not only the symptom score: good ADHD care weighs symptoms alongside day-to-day functioning, quality of life, side effects, other conditions and the person's own goals and preferences.[17]

10 Digital tools & ADHD

Promising, but not a substitute for established treatment

Digital interventions — apps, computerised cognitive training, video games and virtual-reality programmes — are an active area of ADHD research. A 2025 systematic review of 26 reviews found some reported benefits for outcomes such as inattention and executive function, but the underlying evidence was generally low quality, varied a lot between tools, and included reports of adverse effects in some reviews.[18]

The practical takeaway: a clinically studied intervention is not the same as a general productivity or “brain-training” app marketed for ADHD. Digital tools may help some people with specific goals, but they should not be treated as equivalent to established, evidence-based treatments.[18]

11 ADHD across the lifespan

How ADHD can look in adults

ADHD symptoms begin in childhood but often continue into adolescence and adulthood, where they may look different.[7][3] Visible hyperactivity may fade or turn into an inner sense of restlessness, while difficulties with attention, organisation, time-management and follow-through often persist.[7]

Symptoms can become more noticeable when adult responsibilities increase, affecting work, relationships and daily routines.[7] It is never too late to seek assessment and support — effective treatment can make day-to-day life easier.[8]

Good adult care looks beyond symptom checklists to real-world functioning — work, study, relationships and wellbeing — and is built through shared decision-making between the person and their clinician. It also considers co-occurring conditions, sleep and substance use, medication safety (including cardiovascular checks), and the fact that people respond to medicines differently. Medication is an established option but is not mandatory: when it is declined, ineffective or poorly tolerated, psychological and environmental supports matter, and neither approach is a guaranteed replacement for the other.[17][8]

Everyday strategies

Alongside professional treatment, NIMH highlights helpful daily habits: regular physical activity, consistent routines, good sleep, and breaking large tasks into smaller steps.[4] Regular physical activity, in particular, is linked to several potential benefits and may improve perceived sleep quality; the evidence that it reliably increases objectively measured sleep duration is still uncertain, so these are sensible supports rather than proven treatments.[19]

12 Living well with ADHD

A different way of paying attention

With understanding, structure and appropriate treatment, many people with ADHD thrive at school, at work and in relationships.[5] Workplace accommodations, supportive routines and education for families can all make a meaningful difference.[7]

ADHD is best understood not as a barrier to a full life, but as a different way of paying attention to the world — one that, with the right support, can include real strengths. If you think you or someone you know may have ADHD, the most important next step is to speak with a licensed healthcare provider.

The ADHD Report — Sources

Research & references

Every figure and claim above is drawn from the sources listed here. Inline citation numbers throughout the report link to this list.

How this report was put together

This report draws on publicly available information from government health agencies and peer-reviewed research — including the U.S. Centers for Disease Control and Prevention (CDC), the U.S. National Institute of Mental Health (NIMH), the American Academy of Pediatrics (AAP), the American Psychiatric Association's DSM-5-TR, the World Health Organization (WHO), and systematic reviews indexed in the U.S. National Library of Medicine. Statistics reflect the most recent figures available at the time of writing and may be revised as new surveys are published. Parts of the research, drafting and assembly of this site were carried out with the assistance of AI tools; sources were checked against reputable references, but readers should still verify important details against the primary sources linked below.

  1. Centers for Disease Control and Prevention (CDC). Data and Statistics on ADHD. U.S. Department of Health & Human Services. cdc.gov/adhd/data
  2. Danielson ML, Claussen AH, Bitsko RH, et al. ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment. Journal of Clinical Child & Adolescent Psychology, 2024. pmc.ncbi.nlm.nih.gov/articles/PMC11334226
  3. National Institute of Mental Health (NIMH). Attention-Deficit/Hyperactivity Disorder (ADHD) — Health Topic. U.S. National Institutes of Health. nimh.nih.gov/health/topics
  4. National Institute of Mental Health (NIMH). Attention-Deficit/Hyperactivity Disorder: What You Need to Know. nimh.nih.gov/health/publications
  5. Centers for Disease Control and Prevention (CDC). Treatment of ADHD. cdc.gov/adhd/treatment
  6. Centers for Disease Control and Prevention (CDC). Clinical Care and Treatment Recommendations for ADHD — based on the American Academy of Pediatrics (AAP) clinical practice guideline. cdc.gov/adhd/hcp/treatment-recommendations
  7. Centers for Disease Control and Prevention (CDC). ADHD in Adults: An Overview. cdc.gov/adhd/articles/adhd-across-the-lifetime
  8. National Institute of Mental Health (NIMH). ADHD in Adults: 4 Things to Know. nimh.nih.gov/health/publications/adhd-what-you-need-to-know
  9. Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis. Journal of Global Health, 2021;11:04009. pmc.ncbi.nlm.nih.gov/articles/PMC7916320
  10. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: APA, 2022.
  11. Cabral MDI, Liu S, Soares N. Attention-deficit/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth. Translational Pediatrics, 2020;9(Suppl 1):S104–S113. pmc.ncbi.nlm.nih.gov/articles/PMC7082246
  12. Wolraich ML, Hagan JF, Allan C, et al. (American Academy of Pediatrics). Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics, 2019;144(4):e20192528.
  13. Lange KW, Reichl S, Lange KM, et al. The history of attention deficit hyperactivity disorder — peer-reviewed review (U.S. National Library of Medicine). pmc.ncbi.nlm.nih.gov/articles/PMC3000907
  14. World Health Organization (WHO). International Classification of Diseases, 11th Revision (ICD-11) — Attention deficit hyperactivity disorder (6A05). icd.who.int
  15. Young S, Adamo N, Ásgeirsdóttir BB, et al. Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry, 2020;20:404. pmc.ncbi.nlm.nih.gov/articles/PMC7422602
  16. Holden E, et al. Adverse experiences of women with undiagnosed ADHD and the invaluable role of diagnosis (mixed-methods study of 28 women). Scientific Reports, 2025. nature.com/articles/s41598-025-04782-y
  17. Gosling CJ, Ostinelli EG, Cortese S, et al. Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making. BMJ, 2025;391:e085875. bmj.com/content/391/bmj-2025-085875
  18. Gabarron E, Denecke K, Lopez-Campos G. Evaluating the evidence: a systematic review of reviews of the effectiveness and safety of digital interventions for ADHD. BMC Psychiatry, 2025;25:414. bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-025-06825-0
  19. González-Devesa D, et al. Effectiveness of exercise on sleep quality in attention-deficit hyperactivity disorder: a systematic review and meta-analysis. Children, 2025;12(2):119. mdpi.com/2227-9067/12/2/119
  20. Health Resources & Services Administration / Maternal & Child Health Bureau (HRSA/MCHB). Attention-Deficit/Hyperactivity Disorder (ADHD) prevalence and health care access, 2024 — National Survey of Children's Health data brief. ncbi.nlm.nih.gov/books/NBK624161